Who is sponsoring NCT03309189?

NCT03309189 is sponsored by Isabelle Herter-Aeberli.

What condition does NCT03309189 study?

NCT03309189 studies Overweight and Obesity in Schoolchildren.

Is NCT03309189 still recruiting?

NCT03309189 is currently completed. Last updated 13 July 2018.

Last reviewed 2018-07-13 · How we verify

NCT03309189: CHildHNS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Swiss Childhood Health and Nutrition Survey

Completed Last updated 13 July 2018

What this trial tests

trial in Overweight and Obesity in Schoolchildren in 2,292 participants. Completed in 30 June 2018.

Timeline

17 August 2017

Primary endpoint
31 March 2018

30 June 2018

Quick facts

Lead sponsor	Isabelle Herter-Aeberli
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,292
Start date	17 August 2017
Primary completion	31 March 2018
Estimated completion	30 June 2018
Sites	1 location across Switzerland

Conditions studied

Overweight and Obesity in Schoolchildren — all drugs for Overweight and Obesity in Schoolchildren →

Sponsor

Isabelle Herter-Aeberli

Who can join

Adults 6 to 12, any sex, with Overweight and Obesity in Schoolchildren. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to assess the prevalence of overweight and obesity in 6 to 12 year old children in Switzerland. This data will be used to investigate trends in the development of overweight and obesity in Switzerland. In addition, a questionnaire will be used to assess data on physical activity, nutrition, health and socioeconomic background and waist circumference as well as skin fold thicknesses will be measured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Significant Decrease in Childhood Obesity and Waist Circumference over 15 Years in Switzerland: A Repeated Cross-Sectional Study.
Herter-Aeberli I, Osuna E, Sarnovská Z, Zimmermann MB. · · 2019 · cited 12× · PMID 31443303 · DOI 10.3390/nu11081922

Verify or expand the search:

Other Isabelle Herter-Aeberli trials

Trials by the same sponsor.

NCT06655909 — Serum Ferritin Concentration in Kenyan Women and Their Preschool Children at Which the Body Begins to Upregulate Iron Ab · NA · completed
NCT06032234 — Development and Evaluation of a Web-based Diet Quality Screener for Vegans (VEGANScreener) · completed
NCT05788172 — Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique · completed
NCT05697367 — Swiss Childhood Health and Nutrition Survey 2023 · completed
NCT05580783 — Iron Absorption and Variations of Iron Status, Hepcidin, Inflammation and Sex Hormones During the Menstrual Cycle · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03309189 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Isabelle Herter-Aeberli
Last refreshed: 13 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03309189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing